Galderma Korea, which saw the strong performance of its dermal filler Restylane in the first half of this year, said Thursday that this year’s sales are likely to reach 25 billion won thanks to soaring demand for hyaluronic acid filler.
Restylane posted 11.2 billion won in the first-half sales, an increase of 18 percent year-on-year.
“Restylane’s fast growth has been helped by our close c...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.